The Orlistat market is projected to witness a significant growth during the forecast period. The Orlistat market growth is driven by the growing number of weight-loss awareness initiatives. Mainly, orlistat is used as an anti-obesity medication. Orlistat drug is that which aids in the reduction or control of body mass, either by decreasing cravings or increasing calorie consumption.
The rising prevalence of obesity and its related diseases is projected to drive orlistat market expansion. According to a National Family Health Survey done in 2015 in India, over 9.8 million men and over 20 million women are obese. India has the world's second-highest rate of obese children, with the number steadily growing by 3-5 million patients per year.
However, Side effects after consumption of Orlistat drug, patent expiry of blockbuster products, increasing competition in the generic sector, and high cost of the newly launched products are likely to hamper the growth of this market during the forecast period.
Covid-19 Impact on Orlistat Market:
In addition, the current Orlistat Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Orlistat Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Orlistat Market Segment Overview
On the basis of type, the global Orlistat market is segmented into 120mg, and 60mg. The 60mg drug held the major share in the global orlistat market. This segment is anticipated to witness a significant CAGR of over the forecast period. An individual ideally consumes 30% of their energy from fat, the 60-mg dose is better tolerated than the 120-mg dose, and gastrointestinal side effects are minimal. In addition to facilitating modest weight loss are the major factors driving the growth of the market.
In terms of application, the market is segmented into weight-reducing Aid, and Others. Among these weight-reducing aid segment is expected to hold the major share in the global market. The primary application of orlistat is as a weight-loss aid. It is the most effective weight loss medication.
Market Analysis, Insights and Forecast – By Type
· 120mg
· 60mg
· Others
Market Analysis, Insights, and Forecast – By Application
· Weight-reducing Aid
· Others
Orlistat Market Regional Overview
The regional analysis include adoption of Orlistat products across North America, Europe, Asia-Pacific (APAC), Latin America Middle East & Africa (MEA). North America was the leading revenue contributor to the global Orlistat market in 2020. Obesity affects more than one-third of the US population, according to historical statistics. However, Asia-Pacific is expected to experience the fastest CAGR during the forecast period, due to rising demand for orlistat with increasing obesity issues. According to the World Health Organization, nearly 13% of the population was detected to have obesity in 2018. Childhood obesity is on the rise in developing countries, where it is approximately 30% percent higher than in developed countries.
Orlistat Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Orlistat Market, Key Players
· Roche
· GSK group
· Teva
· Sandoz(Novartis)
· STADA-VN J.V.Co., Ltd
· Hexal AG
· National Company for Pharmaceutical Industry
· Lunan Pharmaceutical Group Corporation
· ZEIN pharmaceutical
· HISUN
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Orlistat Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Type
- 5.2.1. 120mg
- 5.2.2. 60mg
- 5.2.3. Others
- 5.3. Market Analysis, Insights, and Forecast – By Application
- 5.3.1. Weight-reducing Aid
- 5.3.2. Others
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America, Middle East, and Africa
6. North America Orlistat Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Type
- 6.2.1. 120mg
- 6.2.2. 60mg
- 6.2.3. Others
- 6.3. Market Analysis, Insights, and Forecast – By Application
- 6.3.1. Weight-reducing Aid
- 6.3.2. Others
- 6.4. Market Analysis, Insights and Forecast – By Country
- 6.4.1. U.S.
- 6.4.2. Canada
7. Europe Orlistat Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Type
- 7.2.1. 120mg
- 7.2.2. 60mg
- 7.2.3. Others
- 7.3. Market Analysis, Insights, and Forecast – By Application
- 7.3.1. Weight-reducing Aid
- 7.3.2. Others
- 7.4. Market Analysis, Insights and Forecast – By Country
- 7.4.1. UK
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Italy
- 7.4.5. Spain
- 7.4.6. Russia
- 7.4.7. Rest of Europe
8. Asia Pacific Orlistat Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Type
- 8.2.1. 120mg
- 8.2.2. 60mg
- 8.2.3. Others
- 8.3. Market Analysis, Insights, and Forecast – By Application
- 8.3.1. Weight-reducing Aid
- 8.3.2. Others
- 8.4. Market Analysis, Insights and Forecast – By Country
- 8.4.1. China
- 8.4.2. India
- 8.4.3. Japan
- 8.4.4. Australia
- 8.4.5. South East Asia
- 8.4.6. Rest of Asia Pacific
9. Latin America, Middle East, and Africa Orlistat Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Type
- 9.2.1. 120mg
- 9.2.2. 60mg
- 9.2.3. Others
- 9.3. Market Analysis, Insights, and Forecast – By Application
- 9.3.1. Weight-reducing Aid
- 9.3.2. Others
- 9.4. Market Analysis, Insights and Forecast – By Country
- 9.4.1. Brazil
- 9.4.2. Saudi Arabia
- 9.4.3. UAE
- 9.4.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2020
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Roche
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. GSK group
- 10.6. Teva
- 10.7. Sandoz (Novartis)
- 10.8. STADA-VN J.V.Co., Ltd
- 10.9. Hexal AG
- 10.10. National Company for Pharmaceutical Industry
- 10.11. Lunan Pharmaceutical Group Corporation
- 10.12. ZEIN pharmaceutical
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
